Collagen Solutions pins hopes on ChrondoMimetic as losses widen
19th Dec 2016 08:43
(ShareCast News) - Medical grade collagen component developer and manufacturer Collagen Solutions posted its results for the six months to 30 September on Monday, with revenue and other income increasing by 30% to £1.89m. The AIM-traded company's adjusted LBITDA was £0.42m, widening from the £0.79m
Read moreDirector dealings: Collagen chairman puts more skin in game
11th Jul 2016 11:03
(ShareCast News) - Collagen Solutions chairman David Evans put more skin in the game on Monday as the company revealed annual losses had tightened up thanks to a plumped-up top line. Serial entrepreneur and small company backer Evans took his stake in the company up to 8.6% by snapping up 900,000
Read moreCollagen Solutions narrows full year losses as revenue surges
11th Jul 2016 08:43
(ShareCast News) - Collagen Solutions, a manufacturer and developer of collagen medical products, narrowed its full year losses as revenue jumped following a new acquisition and investment in patented products. Revenue and other income for the year ending 31 March increased by 213% to £3.2m. The com
Read moreCollagen Solutions joint venture to expand Chinese market
26th Apr 2016 15:28
(ShareCast News) - Developer and manufacturer of medical grade collagen for use in regenerative medicine, Collagen Solutions, announced a new joint venture with Cre8ive on Tuesday in a bid to expand its market in mainland China. The AIM-traded firm said, in order to maximise the potential of its bus
Read moreCollagen Solutions' annual loss widens on expansion plans
13th Jul 2015 10:58
(ShareCast News) - Collagen components manufacturer Collagen Solutions reported a wider annual loss on the back of the expansion of its operations. The London-listed company said its pre-tax loss for the year to 31 March widened from £0.48m to £1.1m, as a sharp jump in revenue was offset by growing
Read moreCollagen Solutions appoints Panmure as sole broker
26th Jun 2015 16:14
Collagen Solutions has appointed Panmure Gordon as its exclusive broker and nominated advisor. The biomaterials manufacturer also granted Panmure with 1.7m new shares via warrant, at a fixed price of 30p per share. The warrants are valid for three years. Panmure will replace Zeus Capital as nominat
Read moreCollagen Solutions signs agreement with Globus Medic
5th Jan 2015 10:34
Medical grade collagen components developer Collagen Solutions announced it had agreed a deal with US-based Globus Medic. Under the agreement, the group will supply fibrous collagen powder for use in the manufacture of Globus' bone grafting products. "Globus utilising our fibrous collagen powder is
Read more